clindamycin has been researched along with Pulmonary Aspergillosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erasmus, J; Mattiuzzi, GN; Sever, M; Verstovsek, S | 1 |
| Acquarolo, A; Carori, G; Fiorese, B; Magri, S; Pantosti, A; Signorini, L; Soavi, L; Stellini, R; Suter, F | 1 |
1 review(s) available for clindamycin and Pulmonary Aspergillosis
| Article | Year |
|---|---|
Mycotic pulmonary artery aneurysm due to Aspergillus infection in a patient with leukemia: case report and review of the literature.
Topics: Abscess; Acyclovir; Amphotericin B; Aneurysm, Infected; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Aspergillus; Caspofungin; Ceftazidime; Clindamycin; Echinocandins; Fluconazole; Humans; Leukemia, Hairy Cell; Lipopeptides; Male; Middle Aged; Mouth; Ofloxacin; Pneumonia; Pulmonary Artery; Pulmonary Aspergillosis; Valacyclovir; Valine; Vancomycin | 2010 |
1 other study(ies) available for clindamycin and Pulmonary Aspergillosis
| Article | Year |
|---|---|
Linezolid and clindamycin improve the outcome of severe, necrotizing pneumonia due to community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).
Topics: Acetamides; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Clindamycin; Combined Modality Therapy; Community-Acquired Infections; Drug Therapy, Combination; Echinocandins; Female; Hemofiltration; Humans; Hydrocortisone; Linezolid; Lipopeptides; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Necrosis; Oxazolidinones; Oxygen Inhalation Therapy; Pneumonia, Bacterial; Pulmonary Aspergillosis; Respiration, Artificial; Shock, Septic; Staphylococcal Infections | 2011 |